COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-10-01
|
| Series: | International Journal of Cardiology: Heart & Vasculature |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906720303298 |
| _version_ | 1818128743187611648 |
|---|---|
| author | Monika Gawałko Agnieszka Kapłon-Cieślicka Mathias Hohl Dobromir Dobrev Dominik Linz |
| author_facet | Monika Gawałko Agnieszka Kapłon-Cieślicka Mathias Hohl Dobromir Dobrev Dominik Linz |
| author_sort | Monika Gawałko |
| collection | DOAJ |
| description | Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients. |
| first_indexed | 2024-12-11T07:38:06Z |
| format | Article |
| id | doaj.art-23b9ae7064a44dc4867ba7230af4f052 |
| institution | Directory Open Access Journal |
| issn | 2352-9067 |
| language | English |
| last_indexed | 2024-12-11T07:38:06Z |
| publishDate | 2020-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | International Journal of Cardiology: Heart & Vasculature |
| spelling | doaj.art-23b9ae7064a44dc4867ba7230af4f0522022-12-22T01:15:40ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672020-10-0130100631COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implicationsMonika Gawałko0Agnieszka Kapłon-Cieślicka1Mathias Hohl2Dobromir Dobrev3Dominik Linz41st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland; Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands; Corresponding author at: 1st Department of Cardiology, Medical University of Warsaw, 1a Banacha St., Warsaw 02-097, Poland.1st Department of Cardiology, Medical University of Warsaw, Warsaw, PolandKlinik für Innere Medizin III, Universität des Saarlandes, Homburg/Saar, GermanyInstitute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, GermanyDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands; Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkCoronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients.http://www.sciencedirect.com/science/article/pii/S2352906720303298AnticoagulationArrhythmiaInflammasomeRemote monitoringThromboembolic risk |
| spellingShingle | Monika Gawałko Agnieszka Kapłon-Cieślicka Mathias Hohl Dobromir Dobrev Dominik Linz COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications International Journal of Cardiology: Heart & Vasculature Anticoagulation Arrhythmia Inflammasome Remote monitoring Thromboembolic risk |
| title | COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications |
| title_full | COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications |
| title_fullStr | COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications |
| title_full_unstemmed | COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications |
| title_short | COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications |
| title_sort | covid 19 associated atrial fibrillation incidence putative mechanisms and potential clinical implications |
| topic | Anticoagulation Arrhythmia Inflammasome Remote monitoring Thromboembolic risk |
| url | http://www.sciencedirect.com/science/article/pii/S2352906720303298 |
| work_keys_str_mv | AT monikagawałko covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications AT agnieszkakapłoncieslicka covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications AT mathiashohl covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications AT dobromirdobrev covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications AT dominiklinz covid19associatedatrialfibrillationincidenceputativemechanismsandpotentialclinicalimplications |